Center for Digestive Allergic and Immunologic Diseases

Williamsville, New York 14221

0 studies enrolling now · 2 studies all time

What they study most

Eosinophilic Esophagitis

Studies at this site

• Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis — Completed
• Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years — Completed